Petrova Penka

CIK 00018380441 companyMISSISSAUGA, A6

SEC Profile

Transactions

Companies

Filings

CIK

0001838044

Recent Transactions

32 trades

Disposition to Issuer
Trillium Therapeutics Inc.
Stock Option (Right to Buy)
2021-11-17−4,574→ 0 total
Disposition to Issuer
Trillium Therapeutics Inc.
Stock Option (Right to Buy)
2021-11-17−83,960→ 0 total
Disposition to Issuer
Trillium Therapeutics Inc.
Stock Option (Right to Buy)
2021-11-17−49,480→ 0 total
Disposition to Issuer
Trillium Therapeutics Inc.
Stock Option (Right to Buy)
2021-11-17−38,808→ 0 total
Disposition to Issuer
Trillium Therapeutics Inc.
Stock Option (Right to Buy)
2021-11-17−140,000→ 0 total
Exercise/Conversion
Trillium Therapeutics Inc.
Common Shares
2021-04-08$3.36/sh+2,604→ 5,312 total
Exercise/Conversion
Trillium Therapeutics Inc.
Stock Option (Right to Buy)
2021-04-08−2,604→ 49,480 total
Exercise/Conversion
Trillium Therapeutics Inc.
Common Shares
2021-04-08$0.30/sh+2,708→ 2,708 total
Sale
Trillium Therapeutics Inc.
Common Shares
2021-04-08$11.09/sh−5,312→ 0 total
Exercise/Conversion
Trillium Therapeutics Inc.
Stock Option (Right to Buy)
2021-04-08−2,708→ 83,960 total
Exercise/Conversion
Trillium Therapeutics Inc.
Stock Option (Right to Buy)
2021-03-10−2,708→ 86,668 total
Exercise/Conversion
Trillium Therapeutics Inc.
Stock Option (Right to Buy)
2021-03-10−2,604→ 52,084 total
Sale
Trillium Therapeutics Inc.
Common Shares
2021-03-10$11.08/sh−5,312→ 0 total
Exercise/Conversion
Trillium Therapeutics Inc.
Common Shares
2021-03-10$3.35/sh+2,604→ 5,312 total
Exercise/Conversion
Trillium Therapeutics Inc.
Common Shares
2021-03-10$0.30/sh+2,708→ 2,708 total
Sale
Trillium Therapeutics Inc.
Common Shares
2021-02-09$14.17/sh−508→ 0 total
Exercise/Conversion
Trillium Therapeutics Inc.
Stock Option (Right to Buy)
2021-02-09−508→ 4,574 total
Exercise/Conversion
Trillium Therapeutics Inc.
Common Shares
2021-02-09$9.62/sh+508→ 508 total
Exercise/Conversion
Trillium Therapeutics Inc.
Common Shares
2021-02-08$0.30/sh+2,708→ 2,708 total
Exercise/Conversion
Trillium Therapeutics Inc.
Common Shares
2021-02-08$3.31/sh+2,604→ 5,312 total
Exercise/Conversion
Trillium Therapeutics Inc.
Stock Option (Right to Buy)
2021-02-08−2,604→ 54,688 total
Sale
Trillium Therapeutics Inc.
Common Shares
2021-02-08$12.65/sh−5,312→ 0 total
Exercise/Conversion
Trillium Therapeutics Inc.
Stock Option (Right to Buy)
2021-02-08−2,708→ 89,376 total
Sale
Trillium Therapeutics Inc.
Common Shares
2021-01-11$15.21/sh−508→ 0 total
Exercise/Conversion
Trillium Therapeutics Inc.
Stock Option (Right to Buy)
2021-01-11−508→ 5,082 total
Exercise/Conversion
Trillium Therapeutics Inc.
Common Shares
2021-01-11$9.57/sh+508→ 508 total
Exercise/Conversion
Trillium Therapeutics Inc.
Common Shares
2021-01-08$3.33/sh+2,604→ 2,604 total
Sale
Trillium Therapeutics Inc.
Common Shares
2021-01-08$15.50/sh−2,604→ 0 total
Exercise/Conversion
Trillium Therapeutics Inc.
Stock Option (Right to Buy)
2021-01-08−2,604→ 57,292 total
Sale
Trillium Therapeutics Inc.
Common Shares
2021-01-07$14.71/sh−2,708→ 0 total
Exercise/Conversion
Trillium Therapeutics Inc.
Common Shares
2021-01-07$0.30/sh+2,708→ 2,708 total
Exercise/Conversion
Trillium Therapeutics Inc.
Stock Option (Right to Buy)
2021-01-07−2,708→ 92,084 total

Companies

Trillium Therapeutics Inc.
Chief Development Officer

Recent Filings

Address

C/O TRILLIUM THERAPEUTICS INC. 2488 DUNWIN DRIVE

MISSISSAUGA, A6, L5L 1J9

View on SEC.gov